Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis by X. Liu et al.
Genome-wide meta-analyses identify three loci associated with
primary biliary cirrhosis
Xiangdong Liu1,41, Pietro Invernizzi2,3,41, Yue Lu4, Roman Kosoy2, Yan Lu1, Ilaria
Bianchi3,5, Mauro Podda3,5, Chun Xu1, Gang Xie1, Fabio Macciardi5,6, Carlo Selmi2,3,5, Sara
Lupoli7, Russell Shigeta2, Michael Ransom2, Ana Lleo2,3,5, Annette T Lee8, Andrew L
Mason9, Robert P Myers10, Kevork M Peltekian11, Cameron N Ghent12, Francesca
Bernuzzi3,5, Massimo Zuin5, Floriano Rosina13, Elisabetta Borghesio13, Annarosa
Floreani14, Roberta Lazzari14, Grazia Niro15, Angelo Andriulli15, Luigi Muratori16, Paolo
Muratori16, Piero L Almasio17, Pietro Andreone16, Marzia Margotti16, Maurizia Brunetto18,
Barbara Coco18, Domenico Alvaro19, Maria C Bragazzi19, Fabio Marra20, Alessandro
Pisano20, Cristina Rigamonti5, Massimo Colombo5, Marco Marzioni21, Antonio Benedetti21,
Luca Fabris14, Mario Strazzabosco22,23, Piero Portincasa24, Vincenzo O Palmieri24, Claudio
Tiribelli25, Lory Croce25, Savino Bruno26, Sonia Rossi26, Maria Vinci27, Cleofe Prisco27,
Alberto Mattalia28, Pierluigi Toniutto29, Antonio Picciotto30, Andrea Galli20, Carlo Ferrari31,
Silvia Colombo32, Giovanni Casella33, Lorenzo Morini34, Nicola Caporaso35, Agostino
Colli36, Giancarlo Spinzi37, Renzo Montanari38, Peter K Gregersen8, E Jenny Heathcote1,39,
Gideon M Hirschfield1,39, Katherine A Siminovitch1,39,40, Christopher I Amos4, M Eric
Gershwin2, and Michael F Seldin2
1University Health Network, Toronto, Ontario, Canada.
2University of California Davis, Davis, California, USA.
3Istituto Di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Clinico Humanitas, Rozzano,
Italy.
4University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
5Università degli Studi di Milano, Milan, Italy.
6University of California, Irvine, California, USA.
7San Raffaele Scientific Institute, Milan, Italy.
8Feinstein Institute for Medical Research, North Shore Long Island Jewish Health System,
Manhasset, New York, USA.
© 2010 Nature America, Inc. All rights reserved.
Correspondence should be addressed to M.F.S. (mfseldin@ucdavis.edu)..
41These authors contributed equally to this work.
AUTHOR CONTRIBUTIONS
X.L., P.I., Yue Lu and R.K. contributed to initial data analyses and manuscript preparation. P.I., R.S., C.S. and A.L. managed DNA
samples. A.L., F. Macciardi, A.T.L. and P.K.G. performed genotyping. M.R. provided database management. P.I., Yan Lu, I.B., M.P.,
C.X., G.X., A.L.M., R.P.M., K.M.P., C.N.G., F.B., M.Z., E.J.H., S.L., F.R., E.B., A.F., R.L., G.N., A.A., L. Muratori, P.M., P.L.A.,
P.A., M. Margotti, M.B., B.C., D.A., M.C.B., F. Marra, A. Pisano, C.R., M.C., M. Marzioni, A.B., L.F., M.S., P.P., V.O.P., C.T., L.C.,
S.B., S.R., M.V., C.P., A.M., P.T., A. Picciotto, A.G., C.F., S.C., G.C., L. Morini, N.C., A.C., G.S. and R.M. contributed to
experimental design, subject assessment and sample collection. P.I., G.M.H., K.A.S., C.I.A., M.E.G. and M.F.S. contributed to
experimental design and interpretation, statistical analyses, and initial manuscript preparation. All authors contributed to the final
paper.
Note: Supplementary information is available on the Nature Genetics website.
COMPETING FINANCIAL INTERESTS
The authors declare no competing financial interests.
NIH Public Access
Author Manuscript
Nat Genet. Author manuscript; available in PMC 2011 August 4.
Published in final edited form as:
Nat Genet. 2010 August ; 42(8): 658–660. doi:10.1038/ng.627.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
9University of Alberta, Edmonton, Alberta, Canada.
10University of Calgary, Calgary, Alberta, Canada.
11Dalhousie University, Halifax, Nova Scotia, Canada.
12London Health Sciences Centre, London, Ontario, Canada.
13Gradenigo Hospital, Turin, Italy.
14University of Padova, Padova, Italy.
15Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo, Italy.
16University of Bologna, Bologna, Italy.
17Università di Palermo, Palermo, Italy.
18Azienda Ospedaliera Universitaria Pisana, Pisa, Italy.
19University Sapienza of Rome, Rome, Italy.
20University of Florence, Florence, Italy.
21Università Politecnica delle Marche, Ancona, Italy.
22Yale University, New Haven, Connecticut, USA.
23University of Milan-Bicocca, Monza, Italy.
24University of Bari, Bari, Italy.
25University of Trieste, Trieste, Italy.
26Ospedale Fatebene Fratelli e Oftalmico, Milan, Italy.
27Ospedale Niguarda, Milan, Italy.
28Santa Croce Carle Hospital, Cuneo, Italy.
29University of Udine, Udine, Italy.
30University of Genoa, Genoa, Italy.
31Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
32Treviglio Hospital, Treviglio, Italy.
33Desio Hospital, Desio, Italy.
34Magenta Hospital, Magenta, Italy.
35Università degli Studi di Napoli ‘Federico II’, Napoli, Italy.
36Department of Internal Medicine, AO Lecco, Lecco, Italy.
37AO Valduce, Como, Italy.
38Ospedale di Negrar, Verona, Italy.
39University of Toronto, Toronto, Ontario, Canada.
40Samuel Lunenfield Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
Abstract
A genome-wide association screen for primary biliary cirrhosis risk alleles was performed in an
Italian cohort. The results from the Italian cohort replicated IL12A and IL12RB associations, and a
combined meta-analysis using a Canadian dataset identified newly associated loci at SPIB (P = 7.9
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× 10–11, odds ratio (OR) = 1.46), IRF5-TNPO3 (P = 2.8 × 10–10, OR = 1.63) and 17q12-21 (P =
1.7 × 10–10, OR = 1.38).
Primary biliary cirrhosis (PBC) is an uncommon condition (with a prevalence of ~5 per
10,000 people) of unknown etiology characterized by chronic cholestatic liver disease and,
frequently, the presence of serum anti-mitochondrial antibodies (AMA). PBC's association
with AMA, other autoantibodies, autoreactive T cells and HLA alleles implies an
autoimmune etiology for this disease1. In addition, the association of PBC with IL12A and
IL12RB2 has previously been demonstrated in a genome-wide association study (GWAS) of
a Canadian PBC cohort2.
To further define the genetic factors conferring risk for PBC, we performed another GWAS
in a cohort of Italian individuals with PBC (cases) and unaffected controls. We analyzed the
data separately using the earlier Canadian PBC GWAS as a replication dataset and then
combined the data with the Canadian GWAS in a meta-analysis. We genotyped Italian PBC
cases and controls using the Illumina 610K array and Illumina 1Mb arrays, respectively.
After quality control filtering and combination with additional European population
controls, we performed principal components analyses, which defined a homogeneous
Italian subject set encompassing 453 PBC cases and 945 controls (Supplementary Methods,
Supplementary Fig. 1 and Supplementary Table 1). The Canadian PBC GWAS (which used
the Illumina 370K array for genotyping) included 481 Canadian PBC cases and 3,706
population controls. We applied association methods controlling for population substructure
to each dataset and used Cochran-Mantel-Haenszel adjustments when combining the
separately analyzed datasets.
We obtained results for the homogeneous Italian subset and the meta-analysis of the entire
sample set (Italian plus Canadian cohorts) (Fig. 1a). The Italian dataset showed genome-
wide significant associations at the HLA region (Fig. 1a,b), with several other loci showing
suggestive association signals. Analysis of the combined dataset showed multiple loci
reaching conservative genome-wide P values (P < 5 × 10–8), including several newly
associated loci (Table 1). For the HLA region, the SNPs showing the strongest associations
nearly overlapped between the two datasets (Fig. 1b). For the Italian cases, the highest- and
lowest-risk haplotypes generally corresponded with high- and low-risk HLA DRB1 alleles3
(χ2 2 × 2 contingency, P = 0.002); however, there was insufficient data for fine mapping.
In the combined data, IL12A and IL12RB2 were the strongest non-HLA associations,
consistent with the previous Canadian GWAS (P = 3.3 × 10–10 and P = 7.5 × 10–12,
respectively) (Supplementary Table 2). SNPs within SCHIP1 (located ~100 kb proximal to
IL12A) also showed suggestive association with PBC (for example, rs3863075, P = 3.05 ×
10–6) in the combined analysis. Independent effects in the IL12A-SCHIP1 interval were
suggested by logistic regression, and risk signals from distinct haplotypes suggested that
multiple and/or independently derived variations underlie the risk association in this region
(Supplementary Table 3). For IL12RB2, a stronger association signal was detected in the
Canadian study cohort relative to the Italian study cohort, but the P value observed for one
SNP (rs3790567, P = 1.5 × 10–3) in the Italian group was among the 500 most strongly
disease-associated SNPs (the most significant 0.1%) in this cohort.
Excluding the MHC region and IL12A, in the Italian cohort, 57 SNPs showed an association
signal with a P < 10–5. Of these, eight SNPs reached significance (using a threshold of P < 8
× 10–4; Supplementary Methods) when the Canadian cohort was used as a replication set,
and most of these SNPs had significant combined P values (Table 1). The significant SNPs
included several in an ~150-kb gene-rich region on chromosome 17 containing IKZF3-
ZPBP2-GSDMB-ORMDL3 that has been implicated in asthma, type 1 diabetes, Crohn's
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disease and ulcerative colitis4–6. A stepwise multiple logistic regression model identified a
single SNP (rs907902) that could account for the observed signal. Within this region, IKZF3
(encoding IKAROS family zinc finger 3, also known as Aiolos) is a transcription factor that
prevents apoptosis of IL2-deprived B cells7, regulates B-cell activation8 and has been
implicated in autoimmunity; a lupus-like syndrome develops in Ikzf3-deficient mice9.
However, although IKZF3 is an attractive association candidate, other genes may also
account for this association signal, including ORMDL3, which has been suggested to
underlie the association with asthma4.
A previously unidentified association resulting from the meta-analysis involved rs3745516
within SPIB (Table 1). A member of the ETS transcription factor family, Spi-B is an
important mediator of both B-cell receptor signaling10 and early T-cell lineage decisions11.
Spi-B also induces the development of plasmacytoid dendritic cells and can mediate IL7R,
c-rel and IFN-γ–induced CD40 expression12. Additional studies are needed to define the
causal mutation at this locus and the biological pathway connecting it to PBC predisposition.
The results from the combined data also support the association at the locus comprising
IRF5 and TNPO3 (encoding interferon regulatory factor 5 and transportin 3, respectively).
Although the Italian PBC cohort showed only modest association at the IRF5-TNPO3 locus
(rs10488631, P = 4.2 × 10–3), the combined P value (P = 2.8 × 10–10) exceeded genome-
wide significant thresholds.
Among the genes with suggestive evidence of association with PBC in the combined
analysis, STAT4 (P = 1.3 × 10–5) and DENND1B (P = 1.8 × 10–4) are noteworthy because of
their prior associations with autoimmune disorders. STAT4 is associated with systemic lupus
erythematosus (SLE) and rheumatoid arthritis13, and its critical role in IL12-IL12R signaling
makes it a strong candidate for influencing PBC risk. DENND1B has recently been
identified as a susceptibility gene in pediatric asthma14. Another suggestive association
signal that may merit further investigation is that for CDGAP (combined P = 1.6 × 10–7).
CDGAP is a noteworthy candidate because the Cdc42 GTPase-activating protein it encodes
is important in lymphocyte development and proliferation15. Other SNPs showed suggestive
signals, but these signals were restricted to either the Italian or Canadian subgroup
(Supplementary Table 2). Additional studies will be needed to ascertain whether these
results can be replicated and whether they are restricted to a particular population subset.
The use of Illumina 610K and Illumina 1Mb arrays enabled an exploration of PBC
association with mitochondrial SNPs, a potentially relevant issue in this AMA-associated
disease. Although these arrays do not interrogate all mitochondrial haplogroups, the lack of
disease association seen here with these SNPs (P > 0.05) suggests that variants in
mitochondrial genes are unlikely to account for PBC heritability or AMA positivity.
Analyses using only AMA-positive PBC cases also showed odds ratios similar to those
observed with the entire set, and the odds ratios from each group showed strong correlation
to each other (r2 odds ratios = 0.95), implying a similar genetic etiology regardless of AMA
status (Supplementary Table 4).
Multiple genes implicated in PBC are apparently shared between different autoimmune
diseases. This includes IL12A, which is shared with celiac disease; however, the SNPs and
haplotypes containing the risk alleles are distinctly different for the two diseases
(Supplementary Table 5). Similarly, PBC appears to be associated with at least one (the
17q12-21 locus, also shared with other autoimmune diseases) and possibly a second
(DENND1B) locus implicated in pediatric asthma. For the 17q12-21 association, however,
the haplotype is opposite that observed in pediatric asthma (Supplementary Fig. 2), and for
DENND1B, the suggestive association also appears to be disparate from that observed with
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asthma. Finally, the associated SNP for IRF5-TNPO3 is within a haplotype shared with SLE
and several other autoimmune diseases. In contrast, many of the other prominent
associations observed in SLE, celiac disease and asthma are not apparent in PBC. Although
the specific genes and variants responsible for the association signals discovered here
remain to be defined, the current findings suggest specific molecular pathways as factors in
the pathogenesis of PBC.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Results of genome-wide association tests for PBC. (a,b) The ordinate shows the level of
significance for each SNP along each chromosome (a) or the HLA region (b). The Italian
PBC subset (diamond symbols) and combined European dataset (circle symbols) are shown.
The dashed line corresponds to P = 5 × 10–8.
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